Extramedullary hematopoiesis in breast after neoadjuvant chemotherapy for breast carcinoma

Annals of Clinical and Laboratory Science

Volumn 36, Issue 4, 2006, Pages 475-478

  Wang, Jun ^a   Darvishian, Farbod ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast; Extramedullary hematopoiesis; Neoadjuvant chemotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; ARTICLE; BREAST CARCINOMA; CASE REPORT; CELL INFILTRATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; HEMATOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MYELOPOIESIS; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HEMATOPOIESIS, EXTRAMEDULLARY; HUMANS; MASTECTOMY; PACLITAXEL;

EID: 33751207757     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Weinstein IM. Idiopathic myelofibrosis: historical review, diagnosis and management. Blood Rev 1991;5: 98-104.
2. Thiele J, Bennewitz FG, Bertsch HP, Falk S, Fischer R, Stutte HJ. Splenic haematopoiesis in primary (idiopathic) osteomyelofibrosis: immunohistochemical and morphometric evaluation of proliferative activity of erythro- and endoreduplicative capacity of megakaryopoiesis (PCNA- and Ki67 staining). Virchows Arch B Cell Pathol Incl Mol Pathol 1993;64:281-286.
3. Redmond J. 3rd, Kantor RS, Auerbach HE, Spiritos MD, Moore JT. Extramedullary hematopoiesis during therapy with granulocyte colony-stimulating factor. Arch Pathol Lab Med 1994;118:1014-1015.
4. Ward HP, Block MH. The natural history of agnogenic myeloid metaplasia and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 1971;50:357-420.
5. Wolf BC, Neiman RS. Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly. Blood 1985;65:803-809.
6. Falk S, Mix D, Stutte HJ. The spleen in osteomyelofibrosis. A morphological and immunohistochemical study of 30 cases. Virchows Arch A Pathol Anat Histopathol 1990; 416:437-442.
7. Tefferi A. Myelofibrosis with myeloid metaplasia. NEJM 2000;342:1255-1265.
8. DiBenedetto J. Jr., Dick JF, Albala M. Anemia and extramedullary hematopoiesis associated with carcinoma of the breast. Ann Clin Res 1977;9:330-334.
9. Cufer T, Bracko M. Myeloid metaplasia of 5he breast. Ann Oncol 2001;12:267-270.
10. Harbin LJ, Burnett S, Ghilchik M, Lee DM, Rajan P. Extramedullary hematopoiesis in a hyalinized mammary fibroadenoma. Histopathology 2002;41:475-477.
11. Malberger E, Hazzani A, Lember S. Extramedullary hematopoiesis in breast aspirates. Acta Cytol 1988;32: 835-837.
12. Zonderland HM, Michiels JJ, ten Kate FJ. Case report: mammographic and sonographic demonstration of extramedullary haematopoiesis of the breast. Clin Radiol 1991;44:64-65.
13. Martinelli G, Santini D, Bazzocchi F, Pileri S, Casanova S. Myeloid metaplasia of the breast. A lesion which clinically mimics carcinoma. Virchows Arch A Pathol Anat Histopathol 1983;401:203-207.
14. Brooks JJ, Krugman DT, Damjanov I. Myeloid metaplasia presenting as a breast mass. Am J Surg Pathol 1980;4:281-285.
15. Setsu Y, Oka K, Naoi Y, et al. Breast carcinoma with myeloid metaplasia-a case report. Pathol Res Pract 1997; 193:219-224.
16. Coyne JD. Extramedullary haemopoiesis. J Clin Pathol 2005;58:448.
17. Comereski CR, Peden WM, Davidson TJ, Warner GL, Hirth RS, Frantz JD. BR96-doxorubicin conjugate (BMS-182248) versus doxorubicin: comparative toxicity assessment in rats. Toxicol Pathol 1994;22:473-488.